首页> 美国卫生研究院文献>Nature Public Health Emergency Collection >Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method
【2h】

Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method

机译:计算方法设计的中东呼吸系统综合症冠状病毒(MERS-CoV)基因沉默的潜在RNAi(miRNA和siRNA)分子。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a virus that manifests itself in viral infection with fever, cough, shortness of breath, renal failure and severe acute pneumonia, which often result in a fatal outcome. MERS-CoV has been shown to spread between people who are in close contact. Transmission from infected patients to healthcare personnel has also been observed and is irredeemable with present technology. Genetic studies on MERS-CoV have shown that ORF1ab encodes replicase polyproteins and play a foremost role in viral infection. Therefore, ORF1ab replicase polyprotein may be used as a suitable target for disease control. Viral activity can be controlled by RNA interference (RNAi) technology, a leading method for post transcriptional gene silencing in a sequence-specific manner. However, there is a genetic inconsistency in different viral isolates; it is a great challenge to design potential RNAi (miRNA and siRNA) molecules which can silence the respective target genes rather than any other viral gene simultaneously. In the current study, four effective miRNA and five siRNA molecules for silencing of nine different strains of MERS-CoV were rationally designed and corroborated using computational methods, which might lead to knockdown the activity of virus. siRNA and miRNA molecules were predicted against ORF1ab gene of different strains of MERS-CoV as effective candidate using computational methods. Thus, this method may provide an insight for the chemical synthesis of antiviral RNA molecule for the treatment of MERS-CoV, at genomic level.
机译:中东呼吸综合征冠状病毒(MERS-CoV)是一种病毒,表现为病毒感染,包括发烧,咳嗽,呼吸急促,肾衰竭和严重的急性肺炎,这通常会导致致命的后果。事实证明,MERS-CoV可以在密切接触的人之间传播。还已经观察到从感染患者到医护人员的传播,并且用当前技术是不可弥补的。对MERS-CoV的遗传研究表明,ORF1ab编码复制酶多蛋白,并在病毒感染中起着首要作用。因此,ORF1ab复制酶多蛋白可用作控制疾病的合适靶标。病毒活性可以通过RNA干扰(RNAi)技术进行控制,这是一种以序列特异性方式沉默转录后基因的领先方法。但是,不同的病毒分离株存在遗传上的不一致。设计潜在的RNAi(miRNA和siRNA)分子是一个巨大的挑战,该分子可以沉默相应的靶基因,而不是同时沉默任何其他病毒基因。在当前的研究中,使用计算方法合理设计和证实了四个有效的miRNA和五个siRNA分子,用于沉默9种不同的MERS-CoV菌株,这可能导致病毒活性下降。使用计算方法预测了针对不同MERS-CoV株ORF1ab基因的siRNA和miRNA分子作为有效候选者。因此,该方法可以为在基因组水平上化学合成用于治疗MERS-CoV的抗病毒RNA分子提供见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号